Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008)
about
Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypesEffects of Hinge Region Natural Polymorphisms on Human Immunodeficiency Virus-1 Protease Structure, Dynamics and Drug-Pressure EvolutionScreening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in ChinaHigh prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South AfricaGenetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International SitesImpact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapyGlobal trends in molecular epidemiology of HIV-1 during 2000-2007.The origin and evolutionary history of HIV-1 subtype C in SenegalImpact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.Major HIV resistance mutations in untreated Romanian patients.Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in EthiopiaProtection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada.Clinical management of HIV drug resistance.Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patientsAntiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents.Psychosocial and cultural correlates of depression among Hispanic men with HIV infection: a pilot study.Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.New subtypes and genetic recombination in HIV type 1-infecting patients with highly active antiretroviral therapy in Peru (2008-2010)Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil.Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistancePulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.Increasing HIV subtype diversity and its clinical implications in a sentinel North American populationHigh rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimenEvaluation of Hologic Aptima HIV-1 Quant Dx Assay on the Panther System on HIV Subtypes.Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens.Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes.Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana.Genetic Variability of HIV-1 for Drug Resistance Assay Development.Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status.A cluster of patients with recombinant B/F HIV-1 infection: epidemiological, clinical, and virological aspects.Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals.
P2860
Q27660028-60F188E3-047A-4E72-86E1-7DECDCAC3315Q27727967-270A305D-BF8A-46AF-B65C-B35FA78592CCQ28485108-9E7E0B77-BB34-490C-8282-97B8F447A193Q28543358-39D4638F-5597-4181-9E40-83D3106D7C6BQ28550335-67585F69-B9B2-42AB-80C8-C5911B4335F9Q30395110-6C8DE0B5-2FC4-4213-A226-7CB76B75A473Q30399382-A0AF888F-D74C-4832-A9A2-A823D256A22AQ30414915-26A84DF8-BEE6-4A82-A5FF-4A9BDCFE36ABQ33683115-9383A32D-C29D-4ECA-AB60-443C4059250FQ33850909-047B98CD-A5EF-4BD2-A2B4-9E29D7AC968EQ34243456-D1C22BFB-43D2-4C62-8EE9-D219949E9DF1Q34489239-89620A02-65DB-4896-8EB2-43B1155E8EE6Q34549498-C2F8A6C2-8A88-4007-A758-9A42CB897F50Q34764036-AC7DFEE2-4C20-43E9-94EA-4972B5456BFDQ35019884-5434B840-7F08-4374-8A89-68A10A3A5DEAQ35071197-2B772D39-7188-4069-8B4B-73582BC8B55EQ35127254-7BBEE18C-E75F-49EF-ACD5-DA08E84A7A7AQ35140323-F82A2676-F7B7-4C86-ACF8-FE6AE5B8FA8CQ35261045-4C73FD79-84CC-4350-98A0-1B00BAA975AAQ35610741-6CF0D347-EAC5-45EA-AEA7-C299358DA973Q35751916-1855DB19-239D-4467-92B0-E5039AA402D7Q35937079-2E6BEB14-D94D-4740-A8E7-57D209C8DA1BQ36418462-4E349A8B-2ADB-4B75-84D0-9DC4841C3B5DQ36429586-BFA38AE6-A8C2-4EAC-A2E3-EB6BE1FDD03DQ36436711-23DDB87E-87B9-4603-81F9-480749054CD2Q36501787-1046A221-5D05-4CA2-982D-83D86F297951Q36593975-D9AE8AFB-B4B4-4831-8DDE-FA966385AE70Q36664640-D1A868A5-513D-48B5-BB05-5B619A2A75EBQ37037315-BBC40298-85A1-40E3-B14F-3AC36E8706ABQ37133188-36F58B64-F902-4C19-83F3-C7F9198CE184Q37280582-BC2B714E-C81C-41C7-80D3-72A20A8CF45DQ37405816-373AC697-F970-4118-AD8B-7F7FF71386BEQ37426900-70C18127-5085-4E3E-B436-CB446BA0A601Q37613239-181343F7-5E0E-4F78-8651-BAE440A05006Q37942538-E476ECC6-1F83-40F1-9ACC-CD4B4B26FEECQ38745545-05E65BDF-FDB9-4EC5-A526-6404D668A83AQ39262818-581E9A9C-2C5B-4940-A09B-93853BE6CC76Q39372763-D77EC0EB-C765-40BA-8A10-5EBA5F877749Q39410511-A968BFEC-EE9D-4ADC-BE25-AA0A1EA46B11Q40918945-77E5FDA9-7BD8-4E2E-B526-DC47D000EB40
P2860
Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences in resistance muta ...... review of evidence (1996-2008)
@en
Differences in resistance muta ...... systematic review of evidence
@nl
type
label
Differences in resistance muta ...... review of evidence (1996-2008)
@en
Differences in resistance muta ...... systematic review of evidence
@nl
prefLabel
Differences in resistance muta ...... review of evidence (1996-2008)
@en
Differences in resistance muta ...... systematic review of evidence
@nl
P2093
P2860
P356
P1476
Differences in resistance muta ...... review of evidence (1996-2008)
@en
P2093
Jorge L Martinez-Cajas
Mark A Wainberg
Nitika P Pai
P2860
P2888
P356
10.1186/1758-2652-12-11
P50
P577
2009-06-30T00:00:00Z
P5875
P6179
1048365286